Prucalopride for constipation in breastfeeding women
Part of Digestive system, Women’s health & pregnancy clinical trials.
This study looks at whether prucalopride (Motegrity/Resotran) can help constipation symptoms in women who are breastfeeding. It also monitors the breastfeeding infant during the study while you follow sample-collection and interview requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older and can consent to the study
- You are currently breastfeeding (or pumping/bottle feeding breast milk) one baby at 10 days to 11 months old
- Your baby is healthy enough for the study (not hospitalized and no major birth defects)
- Your constipation is functional constipation (including chronic idiopathic constipation or IBS-C) and you’ve been taking Motegrity/Resotran as prescribed for at least 5 days while breastfeeding
- You plan to keep breastfeeding and are not starting to wean right now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a probiotic called Lactobacillus can help relieve constipation in pregnant women and improve gut health. It compares the probiotic to a placebo to see if it is safe and effective.
This trial tests if different doses of prucalopride, a medicine that helps the bowels move, can speed up gut function recovery after planned (not emergency) colorectal surgery.
This trial compares two laxatives, prucalopride and bisacodyl, to see which works better at cleaning the colon before a colonoscopy. If you are scheduled for a colonoscopy, you may be able to join and help find the best preparation method.
This study tests whether a probiotic supplement can help relieve constipation in adults. If you have fewer than 3 bowel movements a week or pass hard, lumpy stools, you may be a good fit.
This trial tests whether a probiotic can help people with constipation. You may be eligible if you have fewer than 3 bowel movements per week or hard, lumpy stools.
This trial tests a new drug called CMTS4520 for people with long-term constipation. It aims to see if the drug can help you have more bowel movements without needing laxatives or other help. The study lasts for several months and includes regular check-ups.
Hear when a new Chronic Idiopathic Constipation (CIC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.